Cancer immunology:
Charting the course forward for immunoprofiling
How cells behave in the body depends on numerous factors. Interactions with other cells, through direct contact or via various dissolved factors, are especially important. These interactions not only enable cell survival, but also influence fundamental cellular properties and behaviors. Cancer cells, although aberrant in many respects, are still influenced by their cellular milieu. In fact, associations of cancer cells with the normal peritumoral microenvironment can profoundly impact tumor growth and development. New technologies are coming to the fore that allow interrogation of the types of cells interacting with tumors, in particular providing intelligence on the broad variety of complex associations between tumor cells and the immune system. The depth and breadth of information obtained is promoting biomarker discovery, especially potential targets for drug therapies, as well as possibly enabling improved patient stratification for clinical trials and treatment protocols. Understanding how to obtain this data and how best to use it is critical for future advances in research and cancer treatment.
During this webinar, viewers will:
Learn about the latest approaches to assessing cancer-immune interactions (“immune profiling”) using FFPE tissue sections, multiplexed immunofluorescence, and cell phenotyping software
Better understand the importance of developing robust biomarkers for stratifying patients for clinical trials and for optimized treatment
Be introduced to the latest technologies and methods for automating and standardizing multiplexed IHC methods, and for measuring complex cellular interaction parameters
Have the opportunity to ask questions of our expert panel, live during the broadcast!
The webinar will last approximately 60 minutes.
Cancer immunology:Charting the course forward for immunoprofilingHow cells behave in the body depends on numerous factors. Interactions with other cells, through direct contact or via various dissolved factors, are especially important. These interactions not only enable cell survival, but also influence fundamental cellular properties and behaviors. Cancer cells, although aberrant in many respects, are still influenced by their cellular milieu. In fact, associations of cancer cells with the normal peritumoral microenvironment can profoundly impact tumor growth and development. New technologies are coming to the fore that allow interrogation of the types of cells interacting with tumors, in particular providing intelligence on the broad variety of complex associations between tumor cells and the immune system. The depth and breadth of information obtained is promoting biomarker discovery, especially potential targets for drug therapies, as well as possibly enabling improved patient stratification for clinical trials and treatment protocols. Understanding how to obtain this data and how best to use it is critical for future advances in research and cancer treatment.During this webinar, viewers will:Learn about the latest approaches to assessing cancer-immune interactions (“immune profiling”) using FFPE tissue sections, multiplexed immunofluorescence, and cell phenotyping softwareBetter understand the importance of developing robust biomarkers for stratifying patients for clinical trials and for optimized treatmentBe introduced to the latest technologies and methods for automating and standardizing multiplexed IHC methods, and for measuring complex cellular interaction parametersHave the opportunity to ask questions of our expert panel, live during the broadcast!The webinar will last approximately 60 minutes.
การแปล กรุณารอสักครู่..